Enhanced Category-Based Risk Assessment for Neonatal Early-Onset Sepsis: A Prospective Observational Study
- PMID: 37906986
- PMCID: PMC10836755
- DOI: 10.1159/000534091
Enhanced Category-Based Risk Assessment for Neonatal Early-Onset Sepsis: A Prospective Observational Study
Abstract
Introduction: Compared with multivariate risk assessment, traditional category-based risk assessment (CRA) approaches for neonatal early-onset sepsis (EOS) screening are usually straightforward to use, do not require electronic devices, but are associated with higher rates of antibiotic use. This study aims to evaluate the performance of a novel enhanced CRA (eCRA) framework on EOS admissions and antibiotic use and to investigate whether a modified version with adjustments in risk factor weighting can allow its performance to match the EOS calculator while remaining easy to implement.
Method: This is a prospective, single-center, two-phase observational study. Infants of all gestations delivered in a tertiary hospital in Hong Kong with risk factors or clinical features of EOS were recruited.
Phase i: A novel eCRA framework (period 2) was compared with the CDC 2010-based protocol (period 1).
Phase ii: A modified eCRA framework was compared theoretically with the EOS calculator. EOS-specific admissions and antibiotic use were measured.
Results: Phase I: 1,025 at-risk infants were recruited during period 2 and compared with 757 infants of period 1. Admissions and antibiotic use decreased from 45.8% to 29.4% and 41.1% to 28.2%, respectively. Antibiotics among those at-risk but well-appearing infants decreased from 25.3% to 16.3% (p < 0.001 for all).
Phase ii: antibiotic use was similar (7.3 vs. 6.4%, p = 0.42) between the modified eCRA framework and the EOS calculator.
Conclusions: An eCRA framework can effectively and safely provide individualized guidance for EOS screening without the need for tools such as the EOS calculator.
Keywords: Category-based risk assessment; Neonatal sepsis; Newborn infant.
© 2023 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The other authors have no conflicts of interest to disclose.
Figures
Similar articles
-
Implementation of the Neonatal Sepsis Calculator in an Australian Tertiary Perinatal Centre.Neonatology. 2018;113(4):379-382. doi: 10.1159/000487298. Epub 2018 Mar 7. Neonatology. 2018. PMID: 29514161
-
Introduction of the neonatal sepsis calculator at a low-dependency special care nursery in Australia.J Matern Fetal Neonatal Med. 2022 Dec;35(25):7532-7535. doi: 10.1080/14767058.2021.1951215. Epub 2021 Aug 6. J Matern Fetal Neonatal Med. 2022. PMID: 34353212
-
The impact of the early onset neonatal sepsis calculator on antibiotic initiation: a single center study in Israel.Eur J Pediatr. 2023 Jul;182(7):3187-3194. doi: 10.1007/s00431-023-04993-3. Epub 2023 Apr 29. Eur J Pediatr. 2023. PMID: 37119298
-
Management of neonates at risk of early onset sepsis: a probability-based approach and recent literature appraisal : Update of the Swiss national guideline of the Swiss Society of Neonatology and the Pediatric Infectious Disease Group Switzerland.Eur J Pediatr. 2024 Dec;183(12):5517-5529. doi: 10.1007/s00431-024-05811-0. Epub 2024 Oct 17. Eur J Pediatr. 2024. PMID: 39417838 Free PMC article. Review.
-
Sepsis calculator for neonatal early onset sepsis - a systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2021 Jun;34(11):1832-1840. doi: 10.1080/14767058.2019.1649650. Epub 2019 Aug 11. J Matern Fetal Neonatal Med. 2021. PMID: 31352846
References
-
- Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention CDC . Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1–36. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical